Compare NPCE & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | PACK |
|---|---|---|
| Founded | 1997 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 330.1M |
| IPO Year | 2021 | 2017 |
| Metric | NPCE | PACK |
|---|---|---|
| Price | $16.15 | $4.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $18.33 | $6.50 |
| AVG Volume (30 Days) | 159.4K | ★ 316.2K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $99,986,000.00 | ★ $395,000,000.00 |
| Revenue This Year | $0.90 | $9.29 |
| Revenue Next Year | $24.46 | $8.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | 7.08 |
| 52 Week Low | $7.56 | $2.91 |
| 52 Week High | $18.97 | $6.31 |
| Indicator | NPCE | PACK |
|---|---|---|
| Relative Strength Index (RSI) | 68.02 | 57.79 |
| Support Level | $15.25 | $3.33 |
| Resistance Level | $16.96 | $5.78 |
| Average True Range (ATR) | 0.69 | 0.16 |
| MACD | 0.25 | 0.10 |
| Stochastic Oscillator | 90.19 | 98.00 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.